类器官研究

Search documents
议程发布丨报名即将截止:100%全聚焦类器官与疾病建模、器官芯片与药物筛选、3D细胞培养、类器官培养及质量控制
生物世界· 2025-06-26 08:06
Core Viewpoint - The OTC2025 forum focuses on the advanced applications of organoids and 3D cell culture, discussing topics such as disease modeling, drug screening, AI-driven organ-on-chip technologies, and quality control in organoid cultivation [1][4]. Group 1: Forum Overview - The forum will take place on July 24-25 in Shanghai, featuring over 50 speakers and more than 800 attendees [1]. - Organized by Shanghai Aoshun Pharmaceutical, Shanghai Bai'ao Tai Pharmaceutical Technology, and Yao Jingtong Bio, with support from various academic and medical institutions [1]. Group 2: Agenda Highlights - The main sessions include discussions on tumor organoid drug sensitivity testing, bone organoids, and AI applications in drug screening [4][5]. - Specific topics include retinal organoid technology, high-throughput analysis of tumor organoids, and the application of organoids in disease modeling and drug screening [5][6][7]. Group 3: Key Participants - Notable speakers include experts from prestigious institutions such as Peking University, Macau University, and various research institutes [5][6][7]. - The forum will also feature discussions on the integration of AI in analyzing large-scale organoid data for personalized drug screening [52]. Group 4: Industry Trends - The forum emphasizes the importance of developing automated cultivation systems to enhance organoid production efficiency and reduce costs [54]. - There is a focus on combining 3D bioprinting and microfluidic technologies to improve the complexity and functionality of organoids [54].
一场100%聚焦类器官的千人盛会,30余大咖授课话题曝光丨报名即将截止
生物世界· 2025-06-06 07:58
OTC2025: 产学研医共促类器官技术突破 类器官技术正在快速发展,并逐步进入临床试验阶段。虽然仍面临挑战,但随着生物工程、人工智能和细 胞培养技术的进步,类器官有望成为精准医疗和再生医学的核心工具,为人类健康带来革命性突破。值此 之际, OTC2025 类器官前沿应用与 3D 培养论坛 重磅来袭:围绕 类器官与疾病建模、 3D 细胞培养、 AI+ 器官芯片推进新药研发、类器官培养及质量控制 等角度展开深度探讨。 论坛名称 : OTC2025 类器官前沿应用与 3D 培养论坛 02 为何举办OTC2025 1 利用 AI 分析类器官大规模数据 ,加速个性化药物筛选疾病建模; 2 开发 自动化培养系统 ,提高类器官生产效率,降低成本; 3 结合 3D 生物打印和微流控技术,增加类器官的细胞类型和结构复杂度,以更好地模拟人体微环境; 4 研究如何引入血管系统和免疫细胞,增强类器官的功能性; 5 研发临床级培养基和支架材料,减少批次间差异; 6 建立类器官生物库,为临床应用提供稳定的细胞来源。 举办地点 :上海 论坛规模 : 50 余授课嘉宾, 800 余参会嘉宾 主办单位 :上海傲顺医药、上海佰傲泰医药科技、药 ...